Doctor Pawel Kralisz
Medical University of Bialystok, Bialystok (Poland)
Membership:
EAPCI Member
Follow
Contributor content
Journal
Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals
20 September 2007
